MyAverix Finance
SHG · Healthcare
Cisen Pharmaceutical Co Ltd (603367)
Drug Manufacturers - Specialty & Generic
Cisen Pharmaceutical Co Ltd (603367) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $7.52B, P/E ratio is 15.37, net margin is 13.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603367
Cisen Pharmaceutical Co Ltd (603367) — FAQ
What is Cisen Pharmaceutical Co Ltd's market cap?
Cisen Pharmaceutical Co Ltd (603367) has a reported market cap of $7.52B (data as of 2026-03-29).
What is 603367's P/E ratio?
The price-to-earnings (P/E) ratio for Cisen Pharmaceutical Co Ltd (603367) is 15.37 (data as of 2026-03-29).
Does Cisen Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Cisen Pharmaceutical Co Ltd (603367). Check the MyAverix Finance app for the latest dividend data.
What sector is Cisen Pharmaceutical Co Ltd in?
Cisen Pharmaceutical Co Ltd (603367) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 603367 listed on?
603367 is listed on SHG.
What is Cisen Pharmaceutical Co Ltd's net margin?
Cisen Pharmaceutical Co Ltd (603367) reports a net margin of 13.8% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.